485 related articles for article (PubMed ID: 20591908)
1. Is fascin really a useful marker in distinguishing between classical Hodgkin's lymphoma and various types of non-Hodgkin's lymphomas in difficult cases?
Idrees R; Ahmad Z; Qureshi A; Ahsan A; Pervez S
J Clin Pathol; 2010 Jul; 63(7):571-4. PubMed ID: 20591908
[TBL] [Abstract][Full Text] [Related]
2. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?
Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW
Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270
[TBL] [Abstract][Full Text] [Related]
3. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
4. Comparison of fascin expression in anaplastic large cell lymphoma and Hodgkin disease.
Fan G; Kotylo P; Neiman RS; Braziel RM
Am J Clin Pathol; 2003 Feb; 119(2):199-204. PubMed ID: 12579989
[TBL] [Abstract][Full Text] [Related]
5. Frequent expression of follicular dendritic cell markers in Hodgkin lymphoma and anaplastic large cell lymphoma.
Kim SH; Choe JY; Jeon Y; Huh J; Jung HR; Choi YD; Kim HJ; Cha HJ; Park WS; Kim JE
J Clin Pathol; 2013 Jul; 66(7):589-96. PubMed ID: 23454725
[TBL] [Abstract][Full Text] [Related]
6. Fascin expression in diffuse large B-cell lymphoma, anaplastic large cell lymphoma, and classical Hodgkin lymphoma.
Bakshi NA; Finn WG; Schnitzer B; Valdez R; Ross CW
Arch Pathol Lab Med; 2007 May; 131(5):742-7. PubMed ID: 17488159
[TBL] [Abstract][Full Text] [Related]
7. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.
Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH
Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176
[TBL] [Abstract][Full Text] [Related]
8. Clusterin expression in malignant lymphomas: a survey of 266 cases.
Saffer H; Wahed A; Rassidakis GZ; Medeiros LJ
Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory malignant fibrous histiocytoma: distinction from Hodgkin's disease and non-Hodgkin's lymphoma by a panel of leukocyte markers.
Khalidi HS; Singleton TP; Weiss SW
Mod Pathol; 1997 May; 10(5):438-42. PubMed ID: 9160307
[TBL] [Abstract][Full Text] [Related]
10. Aberrant FHIT protein expression in classical Hodgkin's lymphoma: a potential marker.
Zhao P; Lam AK; Lu YL; Zhong M; Chen LH; Pu XL
Pathology; 2006 Oct; 38(5):399-402. PubMed ID: 17008276
[TBL] [Abstract][Full Text] [Related]
11. Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker.
Pinkus GS; Said JW
Am J Pathol; 1988 Nov; 133(2):211-7. PubMed ID: 3263805
[TBL] [Abstract][Full Text] [Related]
12. Utility of fascin and JunB in distinguishing nodular lymphocyte predominant from classical lymphocyte-rich Hodgkin lymphoma.
Bhargava P; Pantanowitz L; Pinkus GS; Pinkus JL; Paessler ME; Roullet M; Gautam S; Bagg A; Kadin ME
Appl Immunohistochem Mol Morphol; 2010 Jan; 18(1):16-23. PubMed ID: 19550297
[TBL] [Abstract][Full Text] [Related]
13. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
Doussis-Anagnostopoulou IA; Talks KL; Turley H; Debnam P; Tan DC; Mariatos G; Gorgoulis V; Kittas C; Gatter KC
J Pathol; 2002 Aug; 197(5):677-83. PubMed ID: 12210089
[TBL] [Abstract][Full Text] [Related]
15. Morphological and immunohistochemical investigation of non-Hodgkin's lymphoma combined with Hodgkin's disease.
Hansmann ML; Fellbaum C; Hui PK; Lennert K
Histopathology; 1989 Jul; 15(1):35-48. PubMed ID: 2548946
[TBL] [Abstract][Full Text] [Related]
16. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
17. Utility of combining antigranulocyte with antileukocyte antibodies in differentiating Hodgkin's disease from non-Hodgkin's lymphoma.
Medeiros LJ; Weiss LM; Warnke RA; Dorfman RF
Cancer; 1988 Dec; 62(12):2475-81. PubMed ID: 2973368
[TBL] [Abstract][Full Text] [Related]
18. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
[TBL] [Abstract][Full Text] [Related]
19. Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma.
Bräuninger A; Hansmann ML; Strickler JG; Dummer R; Burg G; Rajewsky K; Küppers R
N Engl J Med; 1999 Apr; 340(16):1239-47. PubMed ID: 10210707
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]